ExploreWatchlistsPricing
  1. US-listed companies
  2. ABBOTT LABORATORIES
  3. Financials
  4. Operating expenses

ABBOTT LABORATORIES (ABT)

Market cap
$165.9B
P/E ratio
25.7x
SummaryFinancials
Period EndOperating expenses (Million USD)YoY (%)
Dec 31, 202536,275+3.27%
Dec 31, 202435,125+4.44%
Dec 31, 202333,631-4.70%
Dec 31, 202235,291+1.85%
Dec 31, 202134,650+18.46%
Dec 31, 202029,251+6.86%
Dec 31, 201927,372+1.65%
Dec 31, 201826,928+4.93%
Dec 31, 201725,664+45.26%
Dec 31, 201617,668+0.74%
Dec 31, 201517,538-8.75%
Dec 31, 201319,219-41.94%
Dec 31, 201133,099+13.82%
Dec 31, 201029,079

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat